Primaquine

Janessa Smith, Pharm.D. BCPS, Paul A. Pham, Pharm.D.

INDICATIONS

FDA

  • Malaria treatment or prevention of relapses caused by Plasmodium vivax. Also effective against gametocytes of P. falciparum.

NON-FDA APPROVED USES

  • Treatment of Pneumocystis jirovecii pneumonia (PCP) (in combination with clindamycin).
  • Prevention and treatment of uncomplicated P. ovale malaria
  • Presumptive antirelapse therapy for P. ovale malaria

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: December 11, 2017